Magnetic Resonance Tracking of Transplanted Autologous Bone Marrow-Derived Mesenchymal Stromal Cell in Chronic Spinal Cord Injury at Upper Cervical Level: Case Report

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20140611001

Enrollment

Unknown

Registered

2014-07-03

Start date

2009-02-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal cord injury spinal cord injury mesenchymal stem cells superparamagnatic iron oxide Magnetic resonance imaging tracking

Interventions

BMSCs were retrieved from the patient’s iliac crest and repopulated to the target number. The cells were labeled with superparamegnetic iron oxide (SPIO) before transplantation in to the intrathecal s

Experimental Biological/Vaccine

intrathecal stem cell transplantation

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: injured spinal cord complete or incomplete spinal cord injury at cervical spine level for more than 2 years from traumatic injury

Exclusion criteria

Exclusion criteria: severe medical illness

Design outcomes

Primary

Measure	Time frame
cell migration MRI	—

Secondary

Measure	Time frame
neurological improvements physical examination	—

Countries

Thailand

Contacts

Public ContactAreesak Chotivichit

Faculty of Medicine Siriraj hospital

areesak.cho@mahidol.ac.th0869752949

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Magnetic Resonance Tracking of Transplanted Autologous Bone Marrow&#45;Derived Mesenchymal Stromal Cell in Chronic Spinal Cord Injury at Upper Cervical Level: Case Report